FDA.reportPublic FDA data

pioglitazone HCl 30 MG / glimepiride 2 MG Oral Tablet

RxCUI
647237
RxNorm name
pioglitazone HCl 30 MG / glimepiride 2 MG Oral Tablet
Display name
pioglitazone HCl 30 MG / glimepiride 2 MG Oral Tablet
Full name
pioglitazone HCl 30 MG / glimepiride 2 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
pioglitazone and glimepiridePIOGLITAZONE AND GLIMEPIRIDEPrasco Laboratoriesea385b3d-cb4c-4550-97b0-93a86533f6dc2025-12-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 647237
DuetactPIOGLITAZONE AND GLIMEPIRIDETakeda Pharmaceuticals America, Inc.f8b0c917-3fdd-4a28-a47d-6225b81954582025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 647237

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f8b0c917-3fdd-4a28-a47d-6225b8195458glimepiride 2 MG / pioglitazone 30 MG Oral TabletSCD23These highlights do not include all the information needed to use DUETACT ® safely and effectively. See full prescribing information for DUETACT. DUETACT (pioglitazone and glimepiride) tablets for oral use Initial U.S. Approval: 200620250327
f8b0c917-3fdd-4a28-a47d-6225b8195458glimepiride 2 MG / pioglitazone (as pioglitazone hydrochloride) 30 MG Oral TabletSY23These highlights do not include all the information needed to use DUETACT ® safely and effectively. See full prescribing information for DUETACT. DUETACT (pioglitazone and glimepiride) tablets for oral use Initial U.S. Approval: 200620250327
f8b0c917-3fdd-4a28-a47d-6225b8195458pioglitazone HCl 30 MG / glimepiride 2 MG Oral TabletPSN23These highlights do not include all the information needed to use DUETACT ® safely and effectively. See full prescribing information for DUETACT. DUETACT (pioglitazone and glimepiride) tablets for oral use Initial U.S. Approval: 200620250327
ea385b3d-cb4c-4550-97b0-93a86533f6dcglimepiride 2 MG / pioglitazone 30 MG Oral TabletSCD9These highlights do not include all the information needed to use pioglitazone and glimepiride tablets safely and effectively. See full prescribing information for pioglitazone and glimepiride tablets. Pioglitazone and Glimepiride Tablets, for oral use Initial U.S. Approval: 200620251212
ea385b3d-cb4c-4550-97b0-93a86533f6dcglimepiride 2 MG / pioglitazone (as pioglitazone hydrochloride) 30 MG Oral TabletSY9These highlights do not include all the information needed to use pioglitazone and glimepiride tablets safely and effectively. See full prescribing information for pioglitazone and glimepiride tablets. Pioglitazone and Glimepiride Tablets, for oral use Initial U.S. Approval: 200620251212
ea385b3d-cb4c-4550-97b0-93a86533f6dcpioglitazone HCl 30 MG / glimepiride 2 MG Oral TabletPSN9These highlights do not include all the information needed to use pioglitazone and glimepiride tablets safely and effectively. See full prescribing information for pioglitazone and glimepiride tablets. Pioglitazone and Glimepiride Tablets, for oral use Initial U.S. Approval: 200620251212